(BSCS) Invesco BulletShares 2028 - Ratings and Ratios
Corporate Bonds, Investment Grade, 2028 Maturity, USD Denominated
| Risk via 10d forecast | |
|---|---|
| Volatility | 1.65% |
| Value at Risk 5%th | 2.54% |
| Reward | |
|---|---|
| Sharpe Ratio | 0.70 |
| Alpha Jensen | -6.56 |
| Character | |
|---|---|
| Hurst Exponent | 0.366 |
| Beta | 0.710 |
| Drawdowns 3y | |
|---|---|
| Max DD | 3.95% |
| Mean DD | 0.84% |
Description: BSCS Invesco BulletShares 2028 November 09, 2025
The Invesco BulletShares 2028 Corporate Bond ETF (BSCS) aims to track an index of U.S. dollar-denominated investment-grade corporate bonds that mature, or have effective maturities, in 2028, allocating at least 80 % of its assets to the index constituents.
Key metrics as of the latest reporting period include an average weighted-average maturity of roughly 6.5 years, a yield-to-maturity near 4.2 %, and an expense ratio of 0.20 %. The fund’s credit quality is high, with over 95 % of holdings rated A- or higher, making it sensitive to shifts in the Federal Reserve’s policy rate and corporate earnings trends that influence credit spreads.
For a deeper dive into the fund’s risk-adjusted performance and scenario analysis, you may find ValueRay’s interactive dashboard useful.
BSCS ETF Overview
| Market Cap in USD | 2,940m |
| Category | Target Maturity |
| TER | 0.10% |
| IPO / Inception | 2018-08-09 |
| Return 12m vs S&P 500 | -7.99% |
| Analyst Rating | - |
BSCS Dividends
| Dividend Yield | 4.47% |
| Yield on Cost 5y | 4.71% |
| Yield CAGR 5y | 9.32% |
| Payout Consistency | 95.0% |
| Payout Ratio | - |
BSCS Growth Ratios
| CAGR | 6.10% |
| CAGR/Max DD Calmar Ratio | 1.54 |
| CAGR/Mean DD Pain Ratio | 7.23 |
| Current Volume | 2023.8k |
| Average Volume | 544.1k |
What is the price of BSCS shares?
Over the past week, the price has changed by +0.19%, over one month by +0.20%, over three months by +1.40% and over the past year by +6.23%.
Is Invesco BulletShares 2028 a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BSCS is around 19.75 USD . This means that BSCS is currently overvalued and has a potential downside of -4.08%.
Is BSCS a buy, sell or hold?
What are the forecasts/targets for the BSCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 22.1 | 7.1% |
BSCS Fundamental Data Overview November 11, 2025
Beta = 0.71
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.94b USD (2.94b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.94b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.94b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.63% (E(2.94b)/V(2.94b) * Re(8.63%) + (debt-free company))
Discount Rate = 8.63% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for BSCS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle